Le Lézard
Classified in: Health
Subjects: PER, SBS

Former AstraZeneca Leader Becomes President of Delta Point, Inc.


MALVERN, Pa., March 14, 2018 /PRNewswire/ -- Seeking a leader who will drive growth and continue the company's focus on lifelong learning that engenders high levels of engagement and execution excellence, Jerry Acuff, Delta Point's CEO and founder, has named Matt Murphy to replace him as President.

As Acuff explains, "Murphy's experience in brand consulting, sales training and leadership development combined with his ability to effectively partner with clients and internal colleagues will ensure the company's future and overall growth." He adds, "Matt has always been and continues to be a powerful voice in support of Delta Point's core philosophies including selling by Thinking Like a Customer, the criticality of valuable business relationships, and training sales managers how to coach and teach selling in real time."  

Since beginning his career as a sales specialist for AstraZeneca, Murphy has excelled in leading teams to identify, leverage and optimize sales opportunities. During the last three years of his seventeen-year career at AstraZeneca, Matt was responsible for leading the development and execution of the training curriculum for the 2,000-plus member sales/sales leadership team in the cardiovascular and metabolic business unit.  Murphy earned recognition for shaping regional brand strategies, creating alignment and optimizing resources based on his cross-company efforts in preparation for the successful launch of three brands.

Murphy left AstraZeneca in June 2011, joining Delta Point as Executive Account Director. His commitment to excellence and leadership ability lead to his promotion to Vice-President, and according to Acuff, "those same qualities are what will make him a successful President." Acuff will continue in his role as CEO and will work closely with Murphy on strategic decisions and client relations as Delta Point seeks to expand its industry influence.

About Delta Point, Inc.

Delta Point focuses on identifying and diagnosing those small changes that can make a big difference in driving brand sales. We are most effective in helping organizations that are launching a new product and can't afford to fail; facing new, heavy, or generic competition; challenged with a complex message; or when sales results are not what they should be. Delta Point acknowledges the significance of the sales organization?the first line sales manager and the sales professional?because even with the right strategy and messages, much of the brand's success is based on how the sales professional performs when in front of the customer. Organizational sales excellence requires a commitment across the commercial organization?of Marketing, Sales, Leadership, and Training?and this is exactly where Delta Point can make a difference.

Contact:
Jerry Acuff, CEO
Delta Point, Inc.     
480-296-9972    
E-mail: [email protected]  
http://www.deltapoint.com

SOURCE Delta Point, Inc.


These press releases may also interest you

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....



News published on and distributed by: